Lopinavir/r versus nelfinavir as salvage therapy

被引：1
|
作者：
Resino, S [1 ]
Alvaro-Meca, A
de José, MI
Gurbindo, MD
Ramos, JT
Martin-Fontelos, P
Muñoz-Fernández, MA
机构：
[1] Hosp Gregorio Maranon, Lab Immuno Biol Mol, Madrid, Spain
[2] Hosp La Paz, Serv Pediat, La Paz, Bolivia
[3] Hosp Gregorio Maranon, Serv Inmuno Pediat, Madrid, Spain
[4] Hosp Carlos III, Serv Pediat Infecc, Madrid, Spain
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2005年 / 24卷 / 04期
关键词：
D O I：
10.1097/01.inf.0000157922.19139.90
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：392 / 393
页数：2
相关论文
共 50 条
  • [21] Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir
    Václavíková, J
    Machala, L
    Stanková, M
    Linka, M
    Brucková, M
    Vandasová, J
    Konvalinka, J
    JOURNAL OF CLINICAL VIROLOGY, 2005, 33 (04) : 319 - 323
  • [22] Salvage lopinavir-ritonavir therapy in human immunodeficiency virus-infected children
    Resino, S
    Bellón, JM
    Ramos, JT
    Navarro, ML
    Martín-Fontelos, P
    Cabrero, E
    Muñoz-Fernández, MA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (10) : 923 - 930
  • [23] Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV
    Pulido, Federico
    Arribas, Jose R.
    Delgado, Rafael
    Cabrero, Esther
    Gonzalez-Garcia, Juan
    Perez-Elias, Maria J.
    Arranz, Alberto
    Portilla, Joaquin
    Pasquau, Juan
    Iribarren, Jose A.
    Rubio, Rafael
    Norton, Michael
    AIDS, 2008, 22 (02) : F1 - F9
  • [24] Predictors of virological response in HIV-infected patients to salvage antiretroviral therapy that includes nelfinavir
    Walmsley, SL
    Becker, MI
    Zhang, M
    Humar, A
    Harrigan, PR
    ANTIVIRAL THERAPY, 2001, 6 (01) : 47 - 54
  • [25] Cost-consequence comparison of lopinavir/ritonavir (LPV/r) vs. nelfinavir (NFV) therapy in treating antiretroviral naive hiv patients using clinical trial data
    Luo, MP
    Boggs, B
    Bernstein, B
    Sun, E
    Ashraf, T
    VALUE IN HEALTH, 2002, 5 (06) : 566 - 567
  • [26] AntiretroviralsFirst report of polymyositis with lamivudine, lopinavir/ritonavir and nelfinavir: 2 case reports
    Reactions Weekly, 2005, 1037 (1) : 7 - 7
  • [27] Efficacy of lopinavir/ritonavir (lop/r)-containing salvage regimens in HIV-1 infected patients
    Badri, S
    Falusi, O
    Max, B
    Barker, D
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1204 - 1204
  • [28] Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
    Philippe Henrivaux
    Yvette Fairon
    Benoît Kabamba
    Jean-Cyr Yombi
    Patrick Goubau
    Bernard Vandercam
    Retrovirology, 7
  • [29] A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy
    Cameron, D. William
    da Silva, Barbara A.
    Arribas, Jose R.
    Myers, Robert A.
    Bellos, Nicholaos C.
    Gilmore, Norbert
    King, Martin S.
    Bernstein, Barry M.
    Brun, Scott C.
    Hanna, George J.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (02): : 234 - 240
  • [30] Changes in body fat composition after 1 year of salvage therapy with lopinavir/ritonavir-containing regimens and its relationship with lopinavir plasma concentrations
    Gutiérrez, F
    Padilla, S
    Masiá, M
    Navarro, A
    Gallego, J
    Hernández, I
    Ramos, JM
    Martin -Hidalgo, A
    ANTIVIRAL THERAPY, 2004, 9 (01) : 105 - 113
12345